SCHEMBL22988952

SCHEMBL22988952

c1ccc(-c2ccc(-c3cc(-c4ccc(-n5c6ccc7cccc8oc9cccc%10ccc5c(c%109)c6c78)c5ccccc45)nc(-c4ccccc4)n3)cc2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 6/20 0.36
ALDH1A1 P00352 5/20 0.36
MAPT P10636 5/20 0.36
MEN1 O00255 4/20 0.36
KMT2A Q03164 4/20 0.36
NTSR1 P30989 1/20 0.36
KDM4E B2RXH2 4/20 0.35
LMNA P02545 2/20 0.35
GLA P06280 1/20 0.35
MAOB P27338 4/20 0.33
MAOA P21397 3/20 0.33
MAPK1 P28482 3/20 0.32
TSHR P16473 2/20 0.32
HSD17B10 Q99714 2/20 0.32
CASP1 P29466 1/20 0.32
CASP7 P55210 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
TERT O14746 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
CYP1A1 P04798 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16284593 0.87 MEN1 (0.39) HPGDALDH1A1MAPTMEN1KMT2A
SCHEMBL22988987 0.87 HPGD (0.35) HPGDALDH1A1MAPTMEN1KMT2A
SCHEMBL17179022 0.84 MAPT (0.41) HPGDALDH1A1MAPTMEN1KMT2A
SCHEMBL22989142 0.84 ATR (0.31) HPGDALDH1A1KDM4ELMNACYP1A1
SCHEMBL17178556 0.83 CYP1A1 (0.42) HPGDALDH1A1MAPTMEN1KMT2A
SCHEMBL22988960 0.82 MAPT (0.36) HPGDALDH1A1MAPTKMT2ANTSR1
SCHEMBL16284604 0.82 CYP1A1 (0.37) HPGDALDH1A1MAPTMEN1KMT2A
SCHEMBL17178829 0.81 MAPT (0.40) HPGDALDH1A1MAPTMEN1KMT2A
SCHEMBL17179023 0.81 MAPT (0.41) HPGDALDH1A1MAPTMEN1KMT2A
SCHEMBL16284603 0.81 KDM4E (0.36) HPGDALDH1A1MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021029757-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME 주식회사 엘지화학 2021-02-18 WO disclosed
US-20160340361-A1 PIPERIDINE INHIBITORS OF JANUS KINASE 3 AUSPEX PHARMACEUTICALS, INC. 2016-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160340361-A1 PIPERIDINE INHIBITORS OF JANUS KINASE 3 JAK2, JAK3, PAK3 HPGD 1697/4885ALDH1A1 1603/4885MAPT 2964/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.